Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Satsuma Pharmaceuticals Inc (STSA)

6.46   0 (0%) 03-07 03:55
Open: 6.5 Pre. Close: 6.46
High: 6.85 Low: 6.3001
Volume: 410,031 Market Cap: 113M
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in South San Francisco, California and currently employs 16 full-time employees. The firm is focused on developing a therapeutic product for the treatment of migraine. The Company’s product candidate STS101, is a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate (DHE), which can be self-administered with a proprietary pre-filled, single-use, nasal delivery device.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.856 - 6.89 6.89 - 6.918
Low: 6.225 - 6.261 6.261 - 6.292
Close: 6.405 - 6.462 6.462 - 6.511

Technical analysis

as of: 2021-03-05 5:13:37 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 7.89     One year: 8.72
Support: Support1: 5.59    Support2: 4.65
Resistance: Resistance1: 6.75    Resistance2: 7.47
Pivot: 6.44
Moving Average: MA(5): 6.53     MA(20): 6.55
MA(100): 5.06     MA(250): 14.32
MACD: MACD(12,26): 0.13     Signal(9): 0.17
Stochastic oscillator: %K(14,3): 56.53     %D(3): 53.25
RSI: RSI(14): 52.48
52-week: High: 36.10  Low: 3.50  Change(%): -74.8
Average Vol(K): 3-Month: 51698  10-Days: 66443

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
STSA has closed below upper band by 48.9%. Bollinger Bands are 43.8% wider than normal. The large width of the bands suggest high volatility as compared to STSA's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

Thu, 04 Mar 2021
Where Will Satsuma Pharmaceuticals Inc (STSA) Stock Go Next After It Is Higher By 14.81% in a Week? - InvestorsObserver

Wed, 03 Mar 2021
InvestorNewsBreaks – Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) Featured in Mizuho Securities Research Report -

Wed, 03 Mar 2021
Where Does Wall Street Think Satsuma Pharmaceuticals Inc (STSA) Stock Will Go? - InvestorsObserver

Tue, 02 Mar 2021
Satsuma Pharmaceuticals : Credit Suisse Upgrades Satsuma Pharmaceuticals to Neutral from Underperform After Disclosing Go-Forward Plan STS101 Program -

Tue, 02 Mar 2021
Leerink Partners Maintains Their Hold Rating on Satsuma Pharmaceuticals (STSA) - Smarter Analyst

Mon, 01 Mar 2021
Satsuma Pharmaceuticals Inc (STSA) Stock Is Up 7.57% This Week: Buy, Hold, or Sell? - InvestorsObserver

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 17
Shares Float (M) 9
% Held by Insiders 10.84
% Held by Institutions 56.83
Shares Short (K) 476
Shares Short P. Month (K) 816

Stock Financials

EPS -11.200
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 7.030
Profit Margin
Operating Margin
Return on Assets (ttm) -26.8
Return on Equity (ttm) -45.6
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.693
Qtrly Earnings Growth
Operating Cash Flow (M) -41
Levered Free Cash Flow (M) -26

Stock Valuations

PE Ratio -0.58
PEG Ratio
Price to Book value 0.92
Price to Sales
Price to Cash Flow -2.75

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.